Form 3 Filing for Benitec Biopharma Inc. - Ownership Change

This filing reports a change in beneficial ownership for David Matthew Friedman, a director at Benitec Biopharma Inc. (BNTC). The form, dated May 28, 2026, indicates that Mr. Friedman acquired securities on May 22, 2026. The filing specifies that Mr. Friedman is a director but not an officer or 10% owner. The number of securities owned is stated as 1. The address provided for Mr. Friedman is in New York, NY. This is a standard initial filing for a director regarding their holdings.